Invisalign Attachments for Improved Treatment Planning
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to enhance Invisalign treatments by testing two types of attachments used on teeth. These attachments are tiny, tooth-colored bumps that help aligners fit better and move teeth more easily. The study compares optimized attachments, which are specially designed, to conventional ones to determine which stays on better and maintains its shape longer. Individuals beginning Invisalign treatment, with healthy teeth and gums, might be suitable for this trial. Participants will undergo digital scans of their teeth to assess the effectiveness of the attachments over time. As an unphased trial, this study offers participants the opportunity to contribute to the improvement of Invisalign treatments for future patients.
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications. It seems focused on dental procedures, so it's unlikely that your medications will be affected, but you should confirm with the trial organizers.
What prior data suggests that these Invisalign attachments are safe for use in treatment?
Research has shown that Invisalign attachments are generally safe and well-tolerated. Over time, many people with these attachments feel more comfortable and less self-conscious. Some may experience slight pain when the attachments are first applied or when switching to a new aligner, but this discomfort typically subsides. Studies indicate that normal use can alter the texture and hardness of the attachments, but this does not appear to cause any issues. Overall, these attachments are widely used and considered safe in Invisalign treatments.12345
Why are researchers excited about this trial?
Researchers are excited about this trial because it explores the potential benefits of optimized attachments in Invisalign treatment, which could enhance how aligners move teeth. Optimized attachments are digitally designed to precisely control the direction and retention of force applied by the aligners, potentially improving treatment outcomes compared to the conventional attachments, which use standard shapes. By comparing these two approaches, the trial aims to uncover whether digitally tailored attachments offer superior accuracy and durability, potentially leading to more effective and efficient orthodontic care.
What evidence suggests that this trial's attachments could be effective for improving Invisalign treatment planning?
This trial will compare optimized and conventional attachments used with Invisalign. Research has shown that both types effectively move teeth. Participants in the optimized attachments arm will receive attachments designed to help aligners apply controlled pressure, potentially making tooth movement more precise. Meanwhile, those in the conventional attachments arm will receive attachments that work well for many dental adjustments, such as rotating teeth. Optimized attachments offer better grip and direction, while conventional ones remain reliable. Both types have benefits, and their effectiveness largely depends on the specific dental needs they address.46789
Are You a Good Fit for This Trial?
This trial is for individuals starting Invisalign treatment to correct their teeth alignment. Participants should be receiving these clear aligners as part of their normal dental care and must be willing to have digital scans taken after attachment placement and during follow-ups.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive Invisalign attachments as part of their normal care, with digital scans taken immediately after placement
Follow-up
Participants are monitored for attachment accuracy and wear through digital scans at 1, 3, and 6 months
What Are the Treatments Tested in This Trial?
Interventions
- Composite Aligner Attachment
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Maryland, Baltimore
Lead Sponsor